Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Study Phase : Phase IV
Sponsor : Amsterdam University Medical Center | Frisius Medisch Centrum | Isala | CSL Vifor | Dutch Kidney Foundation | Health Holland
Deal Size : Inapplicable
Deal Type : Inapplicable
Potassium Correction for RAAS Optimization in Chronic Kidney Disease
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 13, 2024
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Sponsor : Amsterdam University Medical Center | Frisius Medisch Centrum | Isala | CSL Vifor | Dutch Kidney Foundation | Health Holland
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : CSL Vifor
Deal Size : Inapplicable
Deal Type : Inapplicable
Patiromer Trial in CKD Stage IIIB to V
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 27, 2023
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : CSL Vifor
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 13, 2023
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Tigermed
Deal Size : Inapplicable
Deal Type : Inapplicable
Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
November 29, 2021
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Tigermed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
June 23, 2020
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Syneos Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 25, 2019
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Syneos Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Exploratory Study of ZG-801 for the Treatment of Hyperkalemia
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 10, 2019
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Study Phase : Phase IV
Sponsor : CSL Vifor
Deal Size : Inapplicable
Deal Type : Inapplicable
Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 19, 2018
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Sponsor : CSL Vifor
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
June 12, 2017
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 22, 2017
Lead Product(s) : Patiromer
Therapeutic Area : Nephrology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable